Overall, these results indicated that NSC745887 could induce DNA damage in GBM cells and activate the ATM/ATR and CHK1/CHK2 pathways; these effects may trigger the arrest of cell-cycle progression at the G2/M phase and promote apoptosis. The gene discussed is CHEK2; the disease is glioblastoma.